BeStock  
Markets › Compare › KRSA vs ZYME

KRSA vs ZYME

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
KRSA · Korsana Biosciences$37.56 ▲ 5.95%
ZYME · Zymeworks$26.14 ▼ 2.68%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

51151250350450Nov 24, '25May 26, '26Nov 20, '26
  • KRSA +260.1%
  • ZYME +4.6%

Head to head

MetricKRSAZYME
Price$37.56$26.14
Change today▲ 5.95%▼ 2.68%
Market cap$1.71B$1.81B
Return, 3 months+36.5%-9.1%
Return, year to date+322.5%-0.7%
Return, 1 year+262.5%+8.8%
P/E (TTM)–49.3
P/B4.47.0
P/E percentile vs own 5y51st100th
Dividend yield––
Revenue growth (YoY, latest qtr)–+828.7%
Net profit growth (YoY)-113.7%+986.1%
Gross margin––
Operating margin–16.6%
Net margin–16.3%
Return on equity-23.2%15.0%
Analyst target vs. price+36.3%+60.0%
Analyst buy share100%100%
RSI (14)7043
30-day volatility60.0%56.5%
Max drawdown, 1 year-54.7%-23.6%
Trend readStrong uptrendLeaning bearish
Analyst consensusBuyBuy

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • ZYME is the largest of the group by market value.
  • KRSA has returned the most over the past year.
  • ZYME has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top